Research Paper Volume 16, Issue 12 pp 10380—10401
Therapeutic targets of formononetin for treating prostate cancer at the single-cell level
Figure 5. Potential binding of formononetin with its target proteins TP53 and CDK1. Molecular docking showed the binding of formononetin with (A) CD74 protein (PDB ID: 4P01), (B) INSR protein (PDB ID: 5E1S), (C) TNF protein (PDB ID: 6X86), and (D) CXCR4 protein (PDB ID: 3ODU).